Reversible Lymphomas Associated with Epstein-Barr Virus Occurring during Methotrexate Therapy for Rheumatoid Arthritis and Dermatomyositis

New England Journal of Medicine

Volumn 328, Issue 18, 1993, Pages 1317-1321

  Kamel, Onsi W ^a   Van de Rijn, Matthijs ^a   Weiss, Lawrence M ^b   Del Zoppo, Gregory J ^c   Hench, P Kahler ^c   Robbins, Bruce A ^c   Montgomery, Paul G ^d   Warnke, Roger A ^a   Dorfman, Ronald F ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

^c SCRIPPS RESEARCH INSTITUTE   (United States)

^d St Luke's Mountain States Tumor Institute   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

METHOTREXATE;

AGED; ARTICLE; CASE REPORT; DERMATOMYOSITIS; EPSTEIN BARR VIRUS; FEMALE; HISTOLOGY; HODGKIN DISEASE; HUMAN; IMMUNE STATUS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; INTRAMUSCULAR DRUG ADMINISTRATION; LARGE CELL LYMPHOMA; LYMPHOMA; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; RISK FACTOR;

AGED; AGED, 80 AND OVER; ARTHRITIS, RHEUMATOID; CASE REPORT; DERMATOMYOSITIS; FEMALE; HERPESVIRUS 4, HUMAN; HODGKIN DISEASE; HUMAN; LYMPHOMA, LARGE-CELL; METHOTREXATE; SUPPORT, U.S. GOV'T, P.H.S.; TUMOR VIRUS INFECTIONS;

EID: 0027310972     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJM199305063281806     Document Type: Article

References (29)

1. Starzl TE, Nalesnik MA, Porter KA, Reversibility of lymphomas and lymphoproliferative lesions developing under cyclosporin-steroid therapy. Lancet 1984; 1:583-587
2. Knowles DM, Chamulak GA, Subar M, Lymphoid neoplasia associated with the acquired immunodeficiency syndrome (AIDS): the New York University Medical Center experience with 105 patients (1981-1986). Ann Intern Med 1988; 108:744-753
3. Nalesnik MA, Jaffe R, Starzl TE, The pathology of posttransplant lymphoproliferative disorders occurring in the setting of cyclosporine A-prednisone immunosuppression. Am J Pathol 1988; 133:173-192
4. Hakulinen T, Isomaki H, Knekt P Rheumatoid arthritis and cancer studies based on linking nationwide registries in Finland. Am J Med 1985; 78: Suppl 1A: 29-32
5. Prior P Cancer and rheumatoid arthritis: epidemiologic considerations. Am J Med 1985; 78: Suppl 1A: 15-21
6. Symmons DPM Neoplasms of the immune system in rheumatoid arthritis. Am J Med 1985; 78: Suppl 1A: 22-28
7. Castor CW, Bull FE Review of United States data on neoplasms in rheumatoid arthritis. Am J Med 1985; 78: Suppl 1A: 33-38
8. Kinlen LJ Incidence of cancer in rheumatoid arthritis and other disorders after immunosuppressive treatment. Am J Med 1985; 78: Suppl 1A: 44-49
9. Bailin PL, Tindall JP, Roenigk HH Jr, Hogan MD Is methotrexate therapy for psoriasis carcinogenic? A modified retrospective-prospective analysis. JAMA 1975; 232:359-362
10. Kremer JM, Lee JK The safety and efficacy of the use of methotrexate in long-term therapy for rheumatoid arthritis. Arthritis Rheum 1986; 29:822-831
11. Weinstein A, Marlowe S, Korn J, Farouhar F Low-dose methotrexate treatment of rheumatoid arthritis: long-term observations. Am J Med 1985; 79:331-337
12. Hazleman B Incidence of neoplasms in patients with rheumatoid arthritis exposed to different treatment regimens. Am J Med 1985; 78: Suppl 1A: 39-43
13. Ellman MH, Hurwitz H, Thomas C, Kozloff M Lymphoma developing in a patient with rheumatoid arthritis taking low dose weekly methotrexate. J Rheumatol 1991; 18:1741-1743
14. Shiroky JB, Frost A, Skelton JD, Haegert DG, Newkirk MM, Neville C Complications of immunosuppression associated with weekly low dose methotrexate. J Rheumatol 1991; 18:1172-1175
15. Bindl JM, Warnke RA Advantages of detecting monoclonal antibody binding to tissue sections with biotin and avidin reagents in Coplin jars. Am J Clin Pathol 1986; 85:490-493
16. Weiss LM, Chen Y, Liu XF, Shibata D Epstein-Barr virus and Hodgkin's disease: a correlative in situ hybridization and polymerase chain reaction study. Am J Pathol 1991; 139:1259-1265
17. Cleary ML, Nalesnik MA, Shearer WT, Sklar J Clonal analysis of transplant-associated lymphoproliferations based on the structure of the genomic termini of the Epstein-Barr virus. Blood 1988; 72:349-352
18. Depper JM, Bluestein HG, Zvaifler NJ Impaired regulation of Epstein-Barr virus-induced lymphocyte proliferation in rheumatoid arthritis is due to a T cell defect. J Immunol 1981; 127:1899-1902
19. Vaughan JH Immune system in rheumatoid arthritis: possible implications in neoplasms. Am J Med 1985; 78: Suppl 1A: 6-11
20. Doyle TJ, Venkatachalam KK, Maeda K, Saeed SM, Tilchen EJ Hodgkin's disease in renal transplant recipients. Cancer 1983; 51:245-247
21. Penn I Malignant lymphomas in organ transplant recipients. Transplant Proc 1981; 13:736-738
22. Chittal SM, Caveriviere P, Schwarting R, Monoclonal antibodies in the diagnosis of Hodgkin's disease: the search for a rational panel. Am J Surg Pathol 1988; 12:9-21
23. Weiss LM, Movahed LA, Warnke RA, Sklar J Detection of Epstein-Barr viral genomes in Reed-Sternberg cells of Hodgkin's disease. N Engl J Med 1989; 320:502-506
24. Pallesen G, Hamilton-Dutoit SJ, Rowe M, Young LS Expression of Epstein-Barr virus latent gene products in tumor cells of Hodgkin's disease. Lancet 1991; 337:320-322
25. Khan G, Coates PJ, Gupta RK, Kangro HO, Slavin G Presence of Epstein-Barr virus in Hodgkin's disease is not exclusive to Reed-Sternberg cells. Am J Pathol 1992; 140:757-762
26. Uccini S, Monardo F, Stoppacciaro A, High frequency of Epstein-Barr virus genome detection in Hodgkin's disease of HIV-positive patients. Int J Cancer 1990; 46:581-585
27. Nalesnik MA, Makowka L, Starzl TE The diagnosis and treatment of posttransplant lymphoproliferative disorders. Curr Probl Surg 1988; 25:365-472
28. Zijlmans JMJM, van Rijthoven AWAM, Kluin PM, Jiwa NM, Dijkmans BAC, Kluin-Nelemans JC Epstein-Barr virus-associated lymphoma in a patient with rheumatoid arthritis treated with cyclosporine. N Engl J Med 1992; 326:1363-1363
29. Tosato G, Steinberg AD, Yarchoan R, Abnormally elevated frequency of Epstein-Barr virus-infected B cells in the blood of patients with rheumatoid arthritis. J Clin Invest 1984; 73:1789-1795